Consolidated Nerve Agent Treatment System
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous Read More